Europe Pancreatic Cancer Diagnostic Market Size & Outlook
The pancreatic cancer diagnostic market in Europe is expected to reach a projected revenue of US$ 1,404.6 million by 2033. A compound annual growth rate of 7.9% is expected of Europe pancreatic cancer diagnostic market from 2026 to 2033.
Revenue, 2025 (US$M)
$778.3
Estimate, 2026 (US$M)
$826.2
Forecast, 2033 (US$M)
$1,404.6
CAGR, 2026 - 2033
7.9%
Global Market
Related Markets
Europe pancreatic cancer diagnostic market highlights
- The Europe pancreatic cancer diagnostic market generated a revenue of USD 778.3 million in 2025.
- The market is expected to grow at a CAGR of 7.9% from 2026 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2025.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 778.3 million |
| Market revenue in 2033 | USD 1,404.6 million |
| Growth rate | 7.9% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.8% of the global pancreatic cancer diagnostic market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,416.0 million by 2033.
No credit card required*
Publish Date: Oct 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Pancreatic Cancer Diagnostic Market Scope
Pancreatic Cancer Diagnostic Market segmentation & scope
Pancreatic Cancer Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
Europe Pancreatic Cancer Diagnostic Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pancreatic Cancer Diagnostic Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.31% in 2025.
Horizon Databook has segmented the Europe pancreatic cancer diagnostic market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Pancreatic Cancer Diagnostic Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Consumables
- Services
- Europe Pancreatic Cancer Diagnostic Market Test Type Outlook (Revenue, USD Million , 2021-2033)
- Imaging Test
- Biopsy
- Blood Test
- Others Test Type
- Europe Pancreatic Cancer Diagnostic Market Cancer Type Outlook (Revenue, USD Million , 2021-2033)
- Exocrine
- Endocrine
- Europe Pancreatic Cancer Diagnostic Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Laboratories
- Others End User
Reasons to subscribe to Pancreatic Cancer Diagnostic Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pancreatic Cancer Diagnostic Market Outlook databook
- Our clientele includes a mix of Pancreatic Cancer Diagnostic Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Pancreatic Cancer Diagnostic Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Pancreatic Cancer Diagnostic Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Pancreatic Cancer Diagnostic Market, 2021-2033 (US$M)
Europe pancreatic cancer diagnostic market statistics, by product, 2021-2033 (US$M)
